COMPANY
PeriCor
We have discovered that these technologies are applicable in the adult market as well and are currently focused on minimally invasive alternatives to surgical procedures to significantly decrease procedural pain, morbidity and mortality. From company website Source · Oct 13, 2026
NIH awards 4
- NIH award 1R41HL174307-01 FY2024: $295,922 awarded for that fiscal year; activity R41 (STTR); PI OPFERMANN, JUSTIN; recipient as written: PERICOR, LLC, BETHESDA, MD. PeriScope: A Novel Videoscope and Toolkit to Enabl source ↗
- NIH award 5R44HL166048-02 FY2023: $850,378 awarded for that fiscal year; activity R44 (SBIR); PI OPFERMANN, JUSTIN; recipient as written: PERICOR, LLC, BETHESDA, MD. PeriPath: A Single Incision Delivery Tool for Epic source ↗
- NIH award 1R44HL166048-01 FY2022: $914,055 awarded for that fiscal year; activity R44 (SBIR); PI OPFERMANN, JUSTIN; recipient as written: PERICOR, LLC, BETHESDA, MD. PeriPath: A Single Incision Delivery Tool for Epic source ↗
- NIH award 1R43HL144352-01 FY2018: $224,730 awarded for that fiscal year; activity R43 (SBIR); PI OPFERMANN, JUSTIN; recipient as written: PERICOR, LLC, BETHESDA, MD. PeriPath: A Novel Pericardial Access Tool for Epic source ↗